Trinity Biotech PLC (TRIB)
1.83
+0.02
(+1.10%)
USD |
NASDAQ |
Apr 23, 16:00
Trinity Biotech Price: 1.83 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 1.895 | 1.895 | 1.82 | 1.83 | 2771.00 |
| Apr 22, 2024 | 1.81 | 1.81 | 1.79 | 1.81 | 1560.00 |
| Apr 19, 2024 | 1.84 | 1.84 | 1.799 | 1.805 | 5746.00 |
| Apr 18, 2024 | 1.80 | 1.88 | 1.79 | 1.88 | 22890.00 |
| Apr 17, 2024 | 1.832 | 1.84 | 1.824 | 1.84 | 3052.00 |
| Apr 16, 2024 | 1.86 | 1.915 | 1.80 | 1.855 | 25502.00 |
| Apr 15, 2024 | 1.84 | 1.915 | 1.84 | 1.91 | 5278.00 |
| Apr 12, 2024 | 1.88 | 1.92 | 1.85 | 1.86 | 13691.00 |
| Apr 11, 2024 | 1.87 | 1.91 | 1.81 | 1.83 | 29571.00 |
| Apr 10, 2024 | 1.86 | 1.94 | 1.86 | 1.929 | 35873.00 |
| Apr 09, 2024 | 1.91 | 2.10 | 1.88 | 1.895 | 74986.00 |
| Apr 08, 2024 | 2.019 | 2.019 | 1.93 | 1.93 | 26240.00 |
| Apr 05, 2024 | 2.00 | 2.10 | 1.97 | 1.98 | 7843.00 |
| Apr 04, 2024 | 2.00 | 2.10 | 1.995 | 2.000 | 13645.00 |
| Apr 03, 2024 | 1.98 | 2.029 | 1.978 | 2.029 | 9738.00 |
| Apr 02, 2024 | 1.970 | 1.970 | 1.94 | 1.96 | 8397.00 |
| Apr 01, 2024 | 1.96 | 2.03 | 1.95 | 1.95 | 7885.00 |
| Mar 28, 2024 | 2.01 | 2.04 | 1.96 | 2.04 | 18211.00 |
| Mar 27, 2024 | 2.057 | 2.115 | 1.98 | 1.98 | 12359.00 |
| Mar 26, 2024 | 2.11 | 2.22 | 1.99 | 2.02 | 23335.00 |
| Mar 25, 2024 | 2.205 | 2.21 | 2.11 | 2.11 | 21184.00 |
| Mar 22, 2024 | 2.12 | 2.170 | 2.12 | 2.12 | 6044.00 |
| Mar 21, 2024 | 2.20 | 2.20 | 2.12 | 2.15 | 42710.00 |
| Mar 20, 2024 | 2.120 | 2.25 | 2.120 | 2.20 | 3988.00 |
| Mar 19, 2024 | 2.156 | 2.25 | 2.12 | 2.19 | 13442.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.805
Minimum
Apr 19 2024
33.20
Maximum
Feb 16 2021
8.409
Average
6.40
Median
Jan 30 2020
Price Benchmarks
| Amarin Corp PLC | 0.8733 |
| Avadel Pharmaceuticals PLC | 17.91 |
| DBV Technologies SA | 0.67 |
| Adaptimmune Therapeutics PLC | 1.095 |
| Akari Therapeutics PLC | 1.19 |
Price Related Metrics
| PS Ratio | 0.196 |
| Earnings Yield | -204.4% |
| Market Cap | 69.92M |